Skip to main content

Table 2 Analysis of the CT features of 347 patients with colorectal cancer [median (Q1, Q3) or no. (%)]

From: Preoperative prediction of microsatellite instability status in colorectal cancer based on a multiphasic enhanced CT radiomics nomogram model

CT features

MSI(n = 71)

MSS(n = 276)

P

Training(n = 243)

Testing(n = 104)

P

cT-stage, n(%)

  

0.106

  

0.096

T1

5(7.04)

7(2.54)

 

7(2.88)

5(4.80)

 

T2

4(5.63)

33(11.96)

 

32(13.17)

5(4.80)

 

T3

58(81.70)

213(77.17)

 

187(76.95)

84(80.78)

 

T4

4(5.63)

23(8.33)

 

17(7.00)

10(9.62)

 

cN-stage, n(%)

  

0.279

  

0.793

N0

38(53.52)

127(46.01)

 

118(48.56)

47(45.19)

 

N1

17(23.94)

60(21.74)

 

54(22.22)

23(22.12)

 

N2

16(22.54)

89(32.25)

 

71(29.22)

34(32.69)

 

Tumour location, n(%)

  

< 0.001

  

0.817

Right colon

37(52.11)

80(28.99)

 

81(33.33)

36(34.62)

 

Left colon or Rectum

34(47.89)

196(71.01)

 

162(66.67)

68(65.38)

 

Tumour length(cm)

46.66(35.27,65.88)

48.06(36.40,62.69)

0.535

48.10(36.78,62.65)

46.33(35.27,63.67)

0.932

Maximum tumour diameter(cm)

18.10(15.08,26.24)

17.69(13.61,24.85)

0.142

17.54(13.67,24.96)

18.38(14.47,25.73)

0.420

Enhancement, n(%)

  

< 0.001

  

0.118

Homogeneous

40(56.34)

238(86.23)

 

200(82.30)

78(75.00)

 

Heterogeneous

31(43.66)

38(13.77)

 

43(17.70)

26(25.00)

 

PCR

0.89(0.82,0.96)

0.92(0.84,1.02)

0.009

0.91(0.83,1.02)

0.92(0.84,1.00)

0.630

ACR

0.21(0.16,0.24)

0.23(0.21,0.26)

< 0.001

0.23(0.20,0.26)

0.22(0.20,0.25)

0.143

VCR

0.46(0.38,0.50)

0.51(0.47,0.56)

< 0.001

0.50(0.45,0.55)

0.51(0.45,0.56)

0.883

DCR

0.64(0.58,0.69)

0.68(0.63,0.73)

< 0.001

0.67(0.63,0.72)

0.68(0.60,0.73)

0.854